Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.27 AUD | -6.33% | -15.44% | -18.82% |
05-28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
05-27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
- Stock Market
- Equities
- NEU Stock
- Charts Neuren Pharmaceuticals Limited
- Total Return chart